Aminu Kano Teaching Hospital   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Kano Nigeria (1988)

Organization Overview

First Clinical Trial
2013
NCT01801423
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Aminu Kano Teaching Hospital | Aminu Kano Teaching Hospital, Kano

Active Ingredients

Drugs in Phase 4 Trials (3)

diclofenac (voltaren) (1 trial)

lidocaine (xylocaine) (1 trial)

selenium (1 trial)

Drugs in Phase 3 Trials (3)

ferric carboxymaltose (Injectafer) (1 trial)

ferrous sulfate (1 trial)

hydroxyurea (hydrea) (4 trials)

Drugs in Phase 2 Trials (1)

lisinopril (zestril) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Albuminuria (Phase 2)

Anemia, Sickle Cell (Phase 3)

Cardiomyopathies (Phase 4)

Disease Susceptibility (Phase 2)

Genetic Predisposition to Disease (Phase 2)

Infertility (Phase 4)

Infertility, Female (Phase 4)

Kidney Diseases (Phase 2)

Stroke (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 7